Status:
COMPLETED
Efficacy and Safety of Ethanol Inhalation on COVID-19 Treatment (a Clinical Trial Study)
Lead Sponsor:
Ali Amoushahi
Collaborating Sponsors:
Isfahan University of Medical Sciences
Conditions:
Clinical Infection
Outcome
Eligibility:
All Genders
12-77 years
Phase:
PHASE3
Brief Summary
Cytokine storm is the cause of many deaths in COVID -19. The antiviral in-vitro effects of ethanol with solving the fat layer and destroying the glycoprotein of coronavirus have already been establish...
Detailed Description
Study Design and Oversight This study is a randomized triple-blind clinical trial with a control group and a parallel design that was conducted at the Isabn-e-Maryam hospital in Medical university of ...
Eligibility Criteria
Inclusion
- Positive RT-PCR test Less than seven days from onset of symptoms
- Agreeing to implement the plan in the form of informed consent
- Age over 12 years
- Not pregnant
- No history of asthma
- Alcoholism
- Epilepsy
- No contraindications to ethanol
Exclusion
- Pregnancy
- Intolerance to inhaled ethanol
- Hypersensitivity
- Allergies to ethanol
- Use of drugs that interact with ethanol
- Partial or incomplete treatment
Key Trial Info
Start Date :
September 2 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 16 2021
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT05268419
Start Date
September 2 2021
End Date
December 16 2021
Last Update
April 25 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Isabn-e-Maryam Hospital
Isfahan, Iran, 8134735945